Surgeon and medical oncologist peer network effects on the uptake of the 21‐gene breast cancer recurrence score assay

BACKGROUND: Drivers behind the adoption of gene expression profiling in breast cancer oncology have been shown to include exposure to physician colleagues’ use of a given genomic test. We examined adoption of the Oncotype DX 21‐gene breast cancer recurrence score assay (ODX) in the United States aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Zipkin, Ronnie, Schaefer, Andrew, Chamberlin, Mary, Onega, Tracy, O'Malley, Alistair J., Moen, Erika L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926024/
https://www.ncbi.nlm.nih.gov/pubmed/33455068
http://dx.doi.org/10.1002/cam4.3720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926024/
https://www.ncbi.nlm.nih.gov/pubmed/33455068
http://dx.doi.org/10.1002/cam4.3720

Ejemplares similares